Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J W Hay

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Clinical Therapeutics|January 1, 1988
Cost-effectiveness of three transdermal nitroglycerin controlled-release systemsJ W Hay
Journal of Health Politics, Policy and Law|January 1, 1983
The impact of public health care financing policies on private-sector hospital costsJ W Hay
Clinical Pharmacology and Therapeutics|August 6, 2008
Using pharmacoeconomics to value pharmacotherapyJ W Hay
Health Policy (Amsterdam, Netherlands)|December 10, 1988
Econometric issues in modeling the costs of AIDSJ W Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Economic modeling and sensitivity analysisJ W Hay
The Annals of Pharmacotherapy|April 1, 1994
Comment: Evaluation of pharmacoeconomic studies: utilization of a checklistJ W Hay
American Journal of Hospital Pharmacy|June 1, 1994
Incorrectly framing pharmacoeconomicsJ W Hay
Health Care Financing Review|January 5, 1985
Home health care cost-function analysisJ W Hay, G Mandes
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2011
Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitorsJ W Hay, Z Y Zhou
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: costs-of-illnessJ W Hay, A R Hay
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Clinical Therapeutics|January 1, 1988
Cost-effectiveness of three transdermal nitroglycerin controlled-release systemsJ W Hay
Journal of Health Politics, Policy and Law|January 1, 1983
The impact of public health care financing policies on private-sector hospital costsJ W Hay
Clinical Pharmacology and Therapeutics|August 6, 2008
Using pharmacoeconomics to value pharmacotherapyJ W Hay
Health Policy (Amsterdam, Netherlands)|December 10, 1988
Econometric issues in modeling the costs of AIDSJ W Hay
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|May 6, 2006
Economic modeling and sensitivity analysisJ W Hay
The Annals of Pharmacotherapy|April 1, 1994
Comment: Evaluation of pharmacoeconomic studies: utilization of a checklistJ W Hay
American Journal of Hospital Pharmacy|June 1, 1994
Incorrectly framing pharmacoeconomicsJ W Hay
Health Care Financing Review|January 5, 1985
Home health care cost-function analysisJ W Hay, G Mandes
Haemophilia : the Official Journal of the World Federation of Hemophilia|June 9, 2011
Economical comparison of APCC vs. rFVIIa for mild-to-moderate bleeding episodes in haemophilia patients with inhibitorsJ W Hay, Z Y Zhou
Journal of Clinical Gastroenterology|June 1, 1992
Inflammatory bowel disease: costs-of-illnessJ W Hay, A R Hay
Pageof 5